Abstract: Radiotherapy is a powerful cure for local advanced non-small cell lung cancer. However, radioresistance and tumor relapse still occur in a high proportion of patients. Octamer-4 (Oct-4), a transcription factor of the POU family, plays a key role in maintaining chemoradioresistant properties and regulating cancer progression. In this study, we demonstrated that Oct-4 expression was significantly increased in radioresistant H460 (H460R) cell line. CpG oligodeoxyribonucleotide (CpG-ODN) 7909 sensitized H460R cells when combined with irradiation treatment. The clonogenic capacity was significantly decreased, and the values of D0 and Dq were lower than those of irradiation alone group. The sensitive enhancement ratio (SER) of D0 was 1.224. This combined treatment led to a dramatic reduction in Oct-4 expression in a dose-dependent manner and also showed increased percentage of cells in the radiosensitive G2/M phase relative to either treatment alone. These results identified that Oct-4 was involved in radioresistance. CpG-ODN 7909 could enhance radiosensitivity partly through downregulating Oct-4 expression in radioresistant lung cancer cells.
Introduction
Lung cancer remains lethal with 5-year survival rate generally lower than 20%, despite intensive therapeutic efforts. 1 As a powerful cure for local advanced non-small cell lung cancer (NSCLC), radiotherapy remains largely palliative like most other antitumor therapies due to the adaptive resistance. 2 Octamer-4 (Oct-4), a transcription factor of the POU family, plays a key role in the maintenance of embryonic stem cell proliferation and pluripotency. 3, 4 Moreover, Oct-4 is also overexpressed in some solid tumors, including breast, bladder, colorectal, renal, and lung cancers, which is associated with the maintenance of cancer stemlike and chemoradioresistant properties. [5] [6] [7] [8] [9] [10] [11] [12] The ectopic expression of Oct-4 controls epithelial-mesenchymal transition and plays an important role in enhancing malignancy and regulating cancer progression. 5, 8, 9, [13] [14] [15] Toll-like receptor 9 (TLR9) has been identified to be the receptor conferring CpG reactivity by directly engaging bacterial DNA or synthetic CpG oligodeoxyribonucleotides (CpG-ODNs) in a CpG motif-dependent manner. [16] [17] [18] [19] [20] Owing to the immunostimulatory effects, CpG-ODNs targeting TLR9 have been considered as antitumor drugs, as monotherapy or in combination with radiotherapy, chemotherapy, or novel biological treatment. 21 In previous studies, we demonstrated that CpG-ODNs present radiation-enhancing effects when combined with radiotherapy, which predominantly attributes to the release of cytokines, activation of natural killer cells, and induction of submit your manuscript | www.dovepress.com
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Xing et al T-cell responses. [22] [23] [24] Because of the overexpression of TLR9 in radiation-resistant human lung adenocarcinoma cell line, CpG-ODNs could even present significant radiosensitizing effects in radioresistant cells in vitro. 25 However, whether CpG-ODNs affect the cancer stem-like properties of radioresistant lung cancer cells has yet to be elucidated. Accordingly, in the present study, we focus on the effects of CpG-ODNs on Oct-4 expression in radiation-resistant lung cancer cell line.
Materials and methods cell culture
The human NCI-H460 NSCLC cell line was purchased from Chinese Academy of Sciences (Shanghai, People's Republic of China) and was cultured in RPMI-1640 medium (HyClone, MA,USA) supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 .
reagents CpG-ODN 7909 (5′-TCGTCGTTTTGTCGTTTTGT CGTT-3′-) was selected according to the published reports and purchased from Shanghai Sangon Biological Engineering Technology & Services Co., Ltd. (Shanghai, People's Republic of China). 23, 25, 26 Chloroquine (CQ), a TLR9 inhibitor, was obtained from Sigma-Aldrich Co. (St Louis, MO, USA). CpG-ODN 7909 and CQ were separately resuspended in phosphate buffer saline to 1 mg/mL stock solutions and maintained at −20°C until use.
generation of radioresistant cell line H460 cells in an exponentially growing phase were irradiated at a dose of 6.37 Gy using a high-energy 6 MV X-ray accelerator delivering 2 Gy/min (source-to-surface distance =100 cm). For the generation of radioresistant variant cell line, cells were treated for ten rounds, and this radioresistant cell line was designated as radioresistant H460 (H460R). 25 study design H460R cells were divided into six groups and plated in sixwell plates (1.5×10 5 /well): control group, CpG-ODN 7909 group (CpG group), irradiated group (IR group), irradiated + CpG-ODN 7909 group (IR + CpG group), irradiated + CpG-ODN 7909 + CQ group (IR + CpG + CQ group), and irradiated + CQ group (IR + CQ group). CpG-ODN 7909 was administrated to a final concentration of 20 µg/mL for 24 hours. CQ was used at a final concentration of 10 µg/ mL in pretreatment during 1 hour prior to stimulation with CpG-ODN 7909. Then, cells were irradiated with 10 Gy.
Logarithmic growing cells of each group were harvested at 48 hours after irradiation (IR).
clonogenic survival assay
Cells that received different treatments were irradiated with graded IR doses ranging from 0 Gy to 8 Gy and then immediately trypsinized and seeded in triplicate in six-well plates (500-3,000 cells per well depending on the expected surviving fraction after IR 27 ). After 10 days of incubation, cells were fixed and stained with crystal violet, and colonies $50 cells were counted. Clonogenic survival fraction was calculated as (irradiated cell colony numbers/unirradiated cell colony numbers) ×100%. Data were analyzed with linear quadratic and single-hit multitarget models.
Western blot analysis
Western blot analysis was used to determine the expression of Oct-4. The whole cell lysate was prepared using the sodium dodecyl sulfate (SDS) lysis buffer (Beyotime, Nantong, People's Republic of China) with 1 mM phenylmethanesulfonyl fluoride (Beyotime). Protein concentration was determined using Coomassie blue fast staining solution (Beyotime). Protein extracts were separated by 10% SDS-polyacrylamide gel electrophoresis, transferred to PVDF membranes (EMD Millipore, Billerica, MA, USA), blocked with 5% nonfat dry milk in tris-buffered saline (TBS) containing 0.1% Tween-20 (TBS-T) for 2 hours at room temperature, and then incubated with the following primary antibodies at 4°C overnight: anti-Oct-4 (Abcam, Cambridge, UK) and anti-β-actin (Santa Cruz, Dallas, TX, USA). Membranes were washed with TBS-T three times and probed with secondary antibodies for 1 hour at room temperature. Protein bands were visualized using chemiluminescence HRP substrate (EMD Millipore).
cell cycle assay
The cell cycle was analyzed by measuring the DNA content stained with propidium iodide in the presence of RNase (BD Biosciences, San Jose, CA, USA) per manufacturer's instructions. The cells were harvested and fixed with 75% ethanol at 4°C overnight and then incubated with 500 µL propidium iodide/RNase staining buffer (BD Biosciences) at room temperature for 15 minutes. 
Results
generation of radioresistant lung cancer cells
The responses to IR between resistant cells and parental cells were analyzed by clonogenic assay. As shown in Figure 1 and Table 1 , in the resistant H460R cells, a marked increase in D0 and N values and a broader initial shoulder were observed as compared to parental H460 cells. H460R cells were more resistant to cell death post-IR at each dose tested. These results indicated the acquired radioresistant characteristics of H460R cells.
elevated expression of Oct-4 in radioresistant lung cancer cells
Since Oct-4 expression plays an important role in regulating cancer progression and maintaining chemoradioresistant properties, we detected the level of Oct-4 in H460 and H460R cells. As shown in Figure 2 , a substantial increase in Oct-4 expression was detected in H460R cells as compared to parental H460 cells, suggesting that Oct-4 was involved in radioresistance, and therefore, the radioresistant lung cancer cells may present more aggressive phenotypes than parental cells. effects of cpg-ODn 7909 on the radiosensitivity of radioresistant lung cancer cells
To assess and characterize the radiation-enhancing effects of CpG-ODN 7909, clonogenic survival analysis was performed. As shown in Figure 4 and Table 2 , CpG-ODN 7909 presented significant radiation-enhancing effects. H460R cells treated with CpG-ODN 7909 plus IR exhibited decreased clonogenic capacity and displayed lower values of D0, Dq, and N than those of IR alone group, and the sensitive enhancement ratio (SER) of D0 was1.224. However, after the activation of TLR9 was blocked by CQ, we were unable to detect any radiation-enhancing effects.
effects of cpg-ODn 7909 on cell cycle regulation after ir in radioresistant lung cancer cells
To determine if radiosensitizing effects of CpG-ODN 7909 were related to cell cycle regulation, we performed flow cytometric analysis to determine the number of cells in each cell cycle phase. As shown in Figure 5A and B, combined treatment with IR and CpG-ODN 7909 showed an increased percentage of cells in G2/M phase compared to either treatment alone in H460R cells, which could be blocked by the co-treatment of CQ. The results above suggested that CpG-ODN 7909 allowed H460R cells to produce G2/M arrest through TLR9 signaling.
Discussion
Lung cancer is the most common diagnosed tumor with a poor prognosis. 1 Although radiotherapy has been a powerful 
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Xing et al Notes: The D0, Dq, and N values of h460r cells treated with cpg-ODn 7909 plus ir were much lower relative to h460r cells irradiated alone, indicating the radiosensitization effect of cpg-ODn 7909 plus ir on h460r cells. The ser of D0 was 1.224. however, the radiation-enhancing effects disappeared after Tlr9 activation was inhibited by cQ. Abbreviations: h460r, radioresistant h460; ir, irradiation; cpg-ODn 7909, cpg oligodeoxyribonucleotide 7909; cQ, chloroquine; ser, sensitive enhancement ratio; Tlr9, toll-like receptor 9. cure for locally advanced NSCLC, its efficiency remains limited as tumors develop adaptive response to radiotherapy and become more aggressive, resistant, and invasive. 2 As a positive regulator of tumor dedifferentiation, Oct-4 plays an important role in maintaining the cancer stem-like and chemoradioresistant properties. 10, 12 In the present study, we found that the resistant H460R cells showed a significant increase in Oct-4 expression relative to parental cells, which indicated that Oct-4 was associated with the radioresistant phenotype. Thus, targeting Oct-4 might be an effective approach to interfere with the properties of cancer stem-like cells (CSCs) and improve the efficacy of cancer treatments.
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Xing et al Due to the immune stimulatory effects, CpG-ODNs have been widely used in cancer therapy, eg, treating oral squamous cell carcinoma, brain tumor, breast cancer, and lung cancer. [28] [29] [30] [31] In our previous studies, we have demonstrated that CpG-ODNs could enhance apoptosis, induce prolonged G2/M arrest, and stimulate TNF-α secretion in human NSCLC cells and thereby enhanced radiosensitivity. As TLR9 was overexpressed in radiation-resistant NSCLC cells, CpG-ODNs could even present significant radiosensitizing effects in radioresistant cells in vitro. 23, 25 All these results urged us to further explore the sensitization mechanism of CpG-ODNs and the influence of CpG-ODNs on Oct-4, as Oct-4 is associated with the radioresistant phenotype.
The ectopic expression of Oct-4 controls epithelialmesenchymal transition and plays an important role in regulating cancer progression and maintaining the chemoradioresistant properties. 5, 8, 9, [13] [14] [15] In this study, overexpression of Oct-4 was observed in H460R cells. However, CpG-ODNs induced a dramatic reduction in Oct-4 expression in a dosedependent manner when combined with IR.
TLR9-CpG-DNA interaction is pH dependent and occurs at the acidic pH (6.5-4.5) found in endosomes and lysosomes. CQ, a known TLR9 antagonist, is a weak base that can partition into endosomes and perturb endosomal pH. 32, 33 CQ has been widely used as the inhibitor for endosomal acidification to inhibit the activation of TLR9. [34] [35] [36] [37] In the present study, pretreatment of H460R cells with CQ caused a blockade in the reduction of Oct-4 expression induced by CpG-ODNs, suggesting that CpG-ODNs could reduce the Oct-4 expression through TLR9 signaling and may therefore present radiosensitizing effects. Cell cycle phase determines cells' relative radiosensitivity, with cells being most sensitive in the G2/M phase. 38 As shown above, combined treatment with IR and CpG-ODNs led to the accumulation of cells in the G2/M phase. Once the activation of TLR9 was blocked by CQ, the CpG-ODN-induced G2/M arrest was abrogated. These results further demonstrated that CpG-ODNs sensitized H460R cells when combined with radiotherapy through TLR9 signaling. As shown in Table 2 , the SER of D0 was about 1.224.
In summary, Oct-4 was involved in radioresistance. Combined treatment with CpG-ODNs and IR presented significant radiosensitizing effects partly through downregulating Oct-4 expression. As cancer stem-like cells phenotype is a dynamic process and can be acquired through Oct-4-mediated dedifferentiation, 7, 11, 12 further investigation remains to be performed to study the role of Oct-4 and the related signaling pathway in radioresistance and to explore the direct effect of CpG-ODNs on CSCs.
